» Articles » PMID: 39125811

Nuclear Factor-Kappa-B Mediates the Advanced Glycation End Product-Induced Repression of Gene Expression in 3T3-L1 Adipocytes

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2024 Aug 10
PMID 39125811
Authors
Affiliations
Soon will be listed here.
Abstract

Advanced glycated end products (AGEs) are cytotoxic compounds that are mainly increased in diabetes mellitus (DM), kidney failure, inflammation, and in response to the ingestion of AGE-rich diets. AGEs can also impair glycemic homeostasis by decreasing the expression of the (solute carrier family 2 member 4) gene and its GLUT4 (solute carrier family 2, facilitated glucose transporter member 4) protein in muscle. However, the mechanisms underlying AGE's effect on adipocytes have not been demonstrated yet. This study investigated the effects of AGEs upon /GLUT4 expression in 3T3-L1 adipocytes, as well as the potential role of NFKB (nuclear factor NF-kappa-B) activity in the effects observed. Adipocytes were cultured in the presence of control albumin (CA) or advanced glycated albumin (GA) at concentrations of 0.4, 3.6, and 5.4 mg/mL for 24 h or 72 h. , and mRNAs were measured by RT-qPCR, GLUT4, IKKA/B, and p50/p65 NFKB subunits using Western blotting, and p50/p65 binding into the promoter was analyzed by chromatin immunoprecipitation (ChIP) assay. GA at 0.4 mg/mL increased /GLUT4 expression after 24 h and 72 h (from 50% to 100%), but at 5.4 mg/mL, /GLUT4 expression decreased at 72 h (by 50%). and expression increased after 24 h at all concentrations, but this effect was not observed at 72 h. Furthermore, 5.4 mg/mL of GA increased the p50/p65 nuclear content and binding into at 72 h. In summary, this study reveals AGE-induced and NFKB-mediated repression of /GLUT4 expression. This can compromise the adipocyte glucose utilization, contributing not only to the worsening of glycemic control in DM subjects but also the impairment of glycemic homeostasis in non-DM subjects under the high intake of AGE-rich foods.

References
1.
Negrean M, Stirban A, Stratmann B, Gawlowski T, Horstmann T, Gotting C . Effects of low- and high-advanced glycation endproduct meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus. Am J Clin Nutr. 2007; 85(5):1236-43. DOI: 10.1093/ajcn/85.5.1236. View

2.
Afridi S, Aftab M, Murtaza M, Ghaffar S, Karim A, Mughal U . A new glycotoxins inhibitor attenuates insulin resistance in liver and fat cells. Biochem Biophys Res Commun. 2016; 476(4):188-195. DOI: 10.1016/j.bbrc.2016.05.085. View

3.
Chilelli N, Faggian A, Favaretto F, Milan G, Compagnin C, Dassie F . In vitro chronic glycation induces AGEs accumulation reducing insulin-stimulated glucose uptake and increasing GLP1R in adipocytes. Am J Physiol Endocrinol Metab. 2021; 320(5):E976-E988. DOI: 10.1152/ajpendo.00156.2020. View

4.
Tergaonkar V, Correa R, Ikawa M, Verma I . Distinct roles of IkappaB proteins in regulating constitutive NF-kappaB activity. Nat Cell Biol. 2005; 7(9):921-3. DOI: 10.1038/ncb1296. View

5.
Stirban A, Kotsi P, Franke K, Strijowski U, Cai W, Gotting C . Acute macrovascular dysfunction in patients with type 2 diabetes induced by ingestion of advanced glycated β-lactoglobulins. Diabetes Care. 2012; 36(5):1278-82. PMC: 3631855. DOI: 10.2337/dc12-1489. View